COVID-19 Infection-Related Coagulopathy and Viscoelastic Methods: A Paradigm for Their Clinical Utility in Critical Illness

Hypercoagulability and thrombosis remain a challenge to diagnose and treat in severe COVID-19 infection. The ability of conventional global coagulation tests to accurately reflect in vivo hypo- or hypercoagulability is questioned. The currently available evidence suggests that markedly increased D-dimers can be used in identifying COVID-19 patients who may need intensive care unit (ICU) admission and close monitoring or not. Viscoelastic methods (VMs), like thromboelastography (TEG) and rotational thromboelastometry (ROTEM), estimate the dynamics of blood coagulation. The evaluation of coagulopathy by VMs in severe COVID-19 infection seems an increasingly attractive option. Available evidence supports that COVID-19 patients with acute respiratory failure suffer from severe hypercoagulability rather than consumptive coagulopathy often associated with fibrinolysis shutdown. However, the variability in definitions of both the procoagulant profile and the clinical outcome assessment, in parallel with the small sample sizes in most of these studies, do not allow the establishment of a clear association between the hypercoagulable state and thrombotic events. VMs can effectively provide insight into the pathophysiology of coagulopathy, detecting the presence of hypercoagulability in critically ill COVID-19 patients. However, it remains unknown whether the degree of coagulopathy can be used in order to predict the outcome, establish a diagnosis or guide anticoagulant therapy.

[1]  J. van der Linden,et al.  Rotational thromboelastometry results are associated with care level in COVID-19 , 2020, Journal of Thrombosis and Thrombolysis.

[2]  M. Bruegel,et al.  Higher procoagulatory potential but lower DIC score in COVID-19 ARDS patients compared to non-COVID-19 ARDS patients , 2020, Thrombosis Research.

[3]  T. Lisman,et al.  In vitro hypercoagulability and ongoing in vivo activation of coagulation and fibrinolysis in COVID‐19 patients on anticoagulation , 2020, Journal of Thrombosis and Haemostasis.

[4]  C. Kempton,et al.  Fibrinolysis Shutdown and Thrombosis in A COVID-19 ICU. , 2020, Shock.

[5]  P. Navalesi,et al.  Different Hypercoagulable Profiles in Patients with COVID-19 Admitted to the Internal Medicine Ward and the Intensive Care Unit , 2020, Thrombosis and Haemostasis.

[6]  Luke W Collett,et al.  Evaluation of coagulation status using viscoelastic testing in intensive care patients with coronavirus disease 2019 (COVID-19): An observational point prevalence cohort study , 2020, Australian Critical Care.

[7]  C. Ferrando,et al.  High D dimers and low global fibrinolysis coexist in COVID19 patients: what is going on in there? , 2020, Journal of Thrombosis and Thrombolysis.

[8]  L. Argaud,et al.  Hypofibrinolytic state and high thrombin generation may play a major role in SARS‐COV2 associated thrombosis , 2020, Journal of Thrombosis and Haemostasis.

[9]  M. Bottai,et al.  Rotational Thromboelastometry predicts care level in Covid-19 , 2020, medRxiv.

[10]  B. Trautner,et al.  Thromboelastographic Results and Hypercoagulability Syndrome in Patients With Coronavirus Disease 2019 Who Are Critically Ill , 2020, JAMA network open.

[11]  V. Schini-Kerth,et al.  COVID-19 Related Coagulopathy: A Distinct Entity? , 2020, Journal of clinical medicine.

[12]  J. Thachil,et al.  Coagulopathy of Coronavirus Disease 2019 , 2020, Critical care medicine.

[13]  S. Bonovas,et al.  ROTEM diagnostic capacity for measuring fibrinolysis in neonatal sepsis. , 2020, Thrombosis research.

[14]  V. Siguret,et al.  Understanding pathophysiology of hemostasis disorders in critically ill patients with COVID-19 , 2020, Intensive Care Medicine.

[15]  R. McIntyre,et al.  Fibrinolysis Shutdown Correlation with Thromboembolic Events in Severe COVID-19 Infection , 2020, Journal of the American College of Surgeons.

[16]  Mickaël Ohana,et al.  High risk of thrombosis in patients with severe SARS-CoV-2 infection: a multicenter prospective cohort study , 2020, Intensive Care Medicine.

[17]  F. Frigieri,et al.  Evaluation of coagulation function by rotation thromboelastometry in critically ill patients with severe COVID-19 pneumonia , 2020, Journal of Thrombosis and Thrombolysis.

[18]  P. Navalesi,et al.  COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure , 2020, Thrombosis and Haemostasis.

[19]  L. Menicanti,et al.  The procoagulant pattern of patients with COVID‐19 acute respiratory distress syndrome , 2020, Journal of Thrombosis and Haemostasis.

[20]  G. Grasselli,et al.  Hypercoagulability of COVID‐19 patients in intensive care unit: A report of thromboelastography findings and other parameters of hemostasis , 2020, Journal of Thrombosis and Haemostasis.

[21]  A. Zangrillo,et al.  Microvascular COVID-19 lung vessels obstructive thromboinflammatory syndrome (MicroCLOTS): an atypical acute respiratory distress syndrome working hypothesis , 2020, Critical care and resuscitation : journal of the Australasian Academy of Critical Care Medicine.

[22]  G. Danzi,et al.  Acute pulmonary embolism and COVID-19 pneumonia: a random association? , 2020, European heart journal.

[23]  A. Falanga,et al.  ISTH interim guidance on recognition and management of coagulopathy in COVID‐19 , 2020, Journal of Thrombosis and Haemostasis.

[24]  M. Maegele,et al.  The role of evidence-based algorithms for rotational thromboelastometry-guided bleeding management , 2019, Korean journal of anesthesiology.

[25]  S. Bonovas,et al.  Thromboelastometry for diagnosis of neonatal sepsis-associated coagulopathy: an observational study , 2018, European Journal of Pediatrics.

[26]  C. Longstaff Measuring fibrinolysis: from research to routine diagnostic assays , 2018, Journal of thrombosis and haemostasis : JTH.

[27]  A. Sauaia,et al.  Acute Fibrinolysis Shutdown after Injury Occurs Frequently and Increases Mortality: A Multicenter Evaluation of 2,540 Severely Injured Patients. , 2016, Journal of the American College of Surgeons.

[28]  D. Consonni,et al.  Assessment of Fibrinolysis in Sepsis Patients with Urokinase Modified Thromboelastography , 2015, PloS one.

[29]  N. Mackman,et al.  Multiple roles of the coagulation protease cascade during virus infection. , 2014, Blood.

[30]  N. Juffermans,et al.  Utility of thromboelastography and/or thromboelastometry in adults with sepsis: a systematic review , 2014, Critical Care.

[31]  Bobbie-Jo M. Webb-Robertson,et al.  Mechanisms of Severe Acute Respiratory Syndrome Coronavirus-Induced Acute Lung Injury , 2013, mBio.

[32]  A. Perner,et al.  Consecutive thrombelastography clot strength profiles in patients with severe sepsis and their association with 28-day mortality: a prospective study. , 2013, Journal of critical care.

[33]  S. Stanworth,et al.  The incidence and magnitude of fibrinolytic activation in trauma patients , 2013, Journal of thrombosis and haemostasis : JTH.

[34]  S. Revel-Vilk The conundrum of neonatal coagulopathy. , 2012, Hematology. American Society of Hematology. Education Program.

[35]  A. Mehrabi,et al.  Viscoelastic and aggregometric point‐of‐care testing in patients with septic shock – cross‐links between inflammation and haemostasis , 2012, Acta anaesthesiologica Scandinavica.

[36]  H. Eggebrecht,et al.  Comparison of Thrombelastometry with Simplified Acute Physiology Score II and Sequential Organ Failure Assessment Scores for the Prediction of 30-Day Survival: A Cohort Study , 2011, Shock.

[37]  H. Eggebrecht,et al.  Comparison of thromboelastometry with procalcitonin, interleukin 6, and C-reactive protein as diagnostic tests for severe sepsis in critically ill adults , 2010, Critical care.

[38]  V. Pettilä,et al.  Thromboelastometry in patients with severe sepsis and disseminated intravascular coagulation , 2009, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[39]  J. Takala,et al.  Thromboelastometry for the assessment of coagulation abnormalities in early and established adult sepsis: a prospective cohort study , 2009, Critical care.

[40]  K. Inaba,et al.  Evaluation of rotation thrombelastography for the diagnosis of hyperfibrinolysis in trauma patients. , 2008, British journal of anaesthesia.

[41]  T. van der Poll,et al.  Sepsis and Disseminated Intravascular Coagulation , 2003, Journal of Thrombosis and Thrombolysis.

[42]  G. Hadley,et al.  Prediction of neonatal sepsis by thromboelastography , 1997, Pediatric Surgery International.

[43]  M. Levi,et al.  DIC: which laboratory tests are most useful. , 2011, Blood reviews.

[44]  江口 和夫,et al.  肝・胆道疾患の Thrombelastography , 1977 .